# Commission Regulation (EU) 2017/1510 of 30 August 2017 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

Annex XVII to Regulation (EC) No 1907/2006 is amended as follows:
(1) in Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein:
‘
1,2-dichloropropane; propylene dichloride
602-020-00-0
201-152-2
78-87-5
e-glass microfibers of representative composition; [Calcium-aluminium-silicate fibres with random orientation with the following representative composition (% given by weight): SiO2 50,0-56,0 %, Al2O3 13,0-16,0 %, B2O3 5,8-10,0 %, Na2O < 0,6 %, K2O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe2O3 < 0,5 %, F2 < 1,0 %. Process: typically produced by flame attenuation and rotary process. (Additional individual elements may be present at low levels; the process list does not preclude innovation).]
014-046-00-4
—
—
’
(2) in Appendix 4, the following entry is inserted in the table in order of the index number set out therein:
‘
3,7-dimethylocta-2,6-dienenitrile
608-067-00-3
225-918-0
5146-66-7
’
(3) in Appendix 5,
(a) the following entries are inserted in the table in order of the index numbers set out therein:
‘
brodifacoum (ISO);
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin
607-172-00-1
259-980-5
56073-10-0
lead powder;
[particle diameter < 1 mm]
082-013-00-1
231-100-4
7439-92-1
lead massive:
[particle diameter ≥ 1 mm]
082-014-00-7
231-100-4
7439-92-1
’
(b) the entry relating to warfarin; 4-hydroxy-3-(3-oxo-1- phenylbutyl)-coumarin is replaced by the following entry:
‘
warfarin (ISO);
4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1]
(S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3]
607-056-00-0
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]
’
(4) in Appendix 6,
(a) the following entries are inserted in the table in order of the index numbers set out therein:
‘
tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol
603-061-00-7
202-625-6
97-99-4
gallium arsenide
031-001-00-4
215-114-8
1303-00-0
Tributyltin compounds, with the exception of those specified elsewhere in this Annex
050-008-00-3
—
—
1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear
607-710-00-5
271-093-5
68515-50-4
imidazole
613-319-00-0
206-019-2
288-32-4
bisphenol A; 4,4′-isopropylidenediphenol
604-030-00-0
201-245-8
80-05-7
phenol, dodecyl-, branched; [1]
phenol, 2-dodecyl-, branched; [2]
phenol, 3-dodecyl-, branched; [3]
phenol, 4-dodecyl-, branched; [4]
phenol, (tetrapropenyl) derivatives [5]
604-092-00-9
310-154-3 [1]
- [2]
- [3]
- [4]
- [5]
121158-58-5 [1]
- [2]
- [3]
210555-94-5 [4]
74499-35-7 [5]
chlorophacinone (ISO);2-[(4-chlorophenyl)(phenyl)acetyl]-1H-indene-1,3(2H)-dione
606-014-00-9
223-003-0
3691-35-8
coumatetralyl (ISO); 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
607-059-00-7
227-424-0
5836-29-3
difenacoum (ISO); 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin
607-157-00-X
259-978-4
56073-07-5
flocoumafen (ISO); reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
607-375-00-5
421-960-0
90035-08-8
disodium octaborate anhydrous; [1]
disodium octaborate tetrahydrate [2]
005-020-00-3
234-541-0 [1]
234-541-0 [2]
12008-41-2 [1]
12280-03-4 [2]
bromadiolone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-one
607-716-00-8
249-205-9
28772-56-7
difethialone (ISO);
3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-one
607-717-00-3
—
104653-34-1
perfluorononan-1-oic acid [1]
and its sodium [2]
and ammonium [3] salts
607-718-00-9
206-801-3 [1]
- [2]
- [3]
375-95-1 [1]
21049-39-8 [2]
4149-60-4 [3]
dicyclohexyl phthalate
607-719-00-4
201-545-9
84-61-7
triflumizole (ISO);
(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimine
612-289-00-6
—
68694-11-1
’
(b) the entry relating to flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl)—2,H 1,4-benzoxazin-6-yl) cyclohex-1-ene-1,2dicarboxamide is replaced by the following entry:
‘
flumioxazin (ISO); 2-[7-fluoro-3-oxo-4- (prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3 (2H)-dione
613-166-00-X
—
103361-09-7
’

---
Source: https://www.legislation.gov.uk/eur/2017/1510/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2017-1510/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.